|
|
| | Eptazocine Basic information |
| Product Name: | Eptazocine | | Synonyms: | (-)-NIH 9614;(-)-ST 2121;1,6-Methano-1H-4-benzazonin-10-ol, 2,3,4,5,6,7-hexahydro-1,4-dimethyl-, hydrobromide, (1S)-;1,6-Methano-1H-4-benzazonin-10-ol, 2,3,4,5,6,7-hexahydro-1,4-dimethyl-, hydrobromide, (1S,6S)-;Sedapain (TN);l-ST-2121;MCV 4169;ST 2121, (-)- | | CAS: | 72150-17-5 | | MF: | C15H22BrNO | | MW: | 312.25 | | EINECS: | | | Product Categories: | | | Mol File: | 72150-17-5.mol |  |
| | Eptazocine Chemical Properties |
| | Eptazocine Usage And Synthesis |
| Description | Eptazocine hydrobromide is a centrally-acting analgesic useful in the management of
post-operative and cancer pain, In animal studies eptazocine exhibits a mixed
agonist/antagonist profile; its analgesic activity is reported to be mediated via opiate
receptors and catecholaminergic neurons. | | Originator | Nichiiko (Japan) | | Uses | Eptazocine Hydrobromide (CAS# 72150-17-5) can be used for various pharmaceutical compounds for improved skin penetration for opioid antagonists due to the presence of fatty acid esters and glycerin fatty acid esters. | | Definition | ChEBI: Eptazocine hydrobromide is a member of tetralins. | | Brand name | Sedapain |
| | Eptazocine Preparation Products And Raw materials |
|